Livero Inc. (TYO:9245)

Livero Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	474	139	77	345	-
Depreciation & Amortization	58	38	33	21	-
Loss (Gain) From Sale of Investments	-	106	-	-	-
Other Operating Activities	-101	19	-130	-103	-
Change in Accounts Receivable	-26	-54	10	-49	-
Change in Accounts Payable	169	66	-73	-6	-
Change in Other Net Operating Assets	254	182	93	122	-
Operating Cash Flow	828	496	10	330	-
Operating Cash Flow Growth	66.94%	4860.00%	-96.97%	-	-
Capital Expenditures	-21	-14	-4	-	-
Sale of Property, Plant & Equipment	2	-	-	-	-
Cash Acquisitions	-50	-	-	-	-
Sale (Purchase) of Intangibles	-112	-98	-63	-57	-
Investment in Securities	-	-	-106	-	-
Other Investing Activities	-265	-184	-143	-69	-
Investing Cash Flow	-456	-320	-316	-126	-
Issuance of Common Stock	16	1	7	668	-
Repurchase of Common Stock	-	-103	-	-	-
Other Financing Activities	-	-	-1	-2	-
Financing Cash Flow	16	-102	6	666	-
Miscellaneous Cash Flow Adjustments	-	-1	1	1	-
Net Cash Flow	388	73	-299	871	-
Free Cash Flow	807	482	6	330	-
Free Cash Flow Growth	67.43%	7933.33%	-98.18%	-	-
Free Cash Flow Margin	22.50%	16.62%	0.24%	13.89%	-
Free Cash Flow Per Share	140.81	85.51	1.03	59.41	-
Cash Income Tax Paid	102	-17	131	103	-
Levered Free Cash Flow	381.38	34.25	-189.25	181.38	-
Unlevered Free Cash Flow	381.38	34.25	-189.25	181.38	-
Change in Working Capital	397	194	30	67	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.